Columbia University. "Nematicity is a new piece in a phase diagram puzzle." ScienceDaily. ScienceDaily, 7 January 2022. <www.sciencedaily.com / releases / 2022 / 01 / 220106133314.htm>.

The Phase 3 PANOVA-3 publication in the Journal of Clinical Oncology, Tumor Treating Fields with gemcitabine and nab-paclitaxel for locally advanced pancreatic adenocarcinoma: randomized, open ...

In a phase I/II trial (AMEERA-1; ClinicalTrials.gov identifier: NCT03284957) in postmenopausal women with ER+/HER2– aBC, most of whom were heavily pretreated, monotherapy with the oral SERD ...

Semaglutide, a glucagon-like peptide-1 receptor agonist, is a candidate for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). In this ongoing phase 3, multicenter ...

In this phase 3, 12-month, double-blind, placebo-controlled trial, we randomly assigned (in a 2:1 ratio) patients who had had an inadequate response to or who had a history of unacceptable side ...